Latest news

Filter by
Date
Sep 13, 2017 12:00 PM

Dubbo Osteoporosis Epidemiology Study

Take 5000 people, scrutinise for three decades and what do you get? A wholly new understanding of osteoporosis for starters, and the insights keep on coming.

Sep 11, 2017 08:51 AM

Vale Connie Johnson OAM

Vale Constance (Connie) Johnson OAM 1977 – 2017.

MEDIA RELEASE: Sep 07, 2017 10:48 PM

‘Partner in crime’ mutations work together to kickstart lymp...

Australian researchers have uncovered ‘extraordinary cooperation’ between two DNA mutations that are often found together in lymphomas and leukaemias. The findings help us understand how immune cells can ‘go rogue’, beha...

Aug 31, 2017 01:20 PM

Professor Mark Febbraio: exercise is medicine

Garvan congratulates Professor Mark Febbraio, who has won the 2017 Australian Diabetes Society (ADS) Kellion Award. The award recognises an Australian researcher who has made an outstanding contribution to diabetes resea...

MEDIA RELEASE: Aug 23, 2017 06:00 AM

Ground-breaking trial brings personalised treatments to thos...

Garvan's Genomic Cancer Medicine Program, launched today by The Hon. Brad Hazzard, uses genomic medicine to match therapies, prevention and screening methods with rare cancer patients based on their genetic information.

Aug 16, 2017 07:09 AM

Rare Cancers Australia sets new agenda for change

Garvan is proud to support Rare Solutions: A Time to Act, a new report released by Rare Cancers Australia that sets out a roadmap for change in the treatment and care of patients with rare cancer in Australia.

MEDIA RELEASE: Aug 04, 2017 01:00 AM

Top-to-toe MRI screen picks up early-stage cancers while sti...

A major study shows that whole-body MRI screening can identify previously undetected primary tumours throughout the body in people with high genetic risk of cancer.

Jul 14, 2017 11:30 AM

Immunotherapy – changing the way we think about cancer treat...

Garvan scientists are looking beyond their specialty areas and taking an inter-disciplinary approach that is changing the way we think about the treatment of cancer.

Jul 07, 2017 11:10 AM

Interleukin-2: releasing an immune system brake to attack tu...

Researchers from Garvan’s Immunology Division have been exploring ways to make interleukin-2 immunotherapy less toxic and more effective against cancer. In doing so, the team has uncovered surprising new information abou...

MEDIA RELEASE: Jun 30, 2017 05:00 AM

Promising new therapeutic approach rebuilds and strengthens ...

Garvan researchers demonstrate that a new therapeutic approach increases bone strength and resistance to fractures in multiple myeloma bone disease

Jun 16, 2017 09:00 PM

When one becomes two: an intricate new roadmap for cell divi...

Dr Andrew Burgess and Professor Sean O’Donoghue have brought Garvan and CSIRO researchers and biodata visualisation specialists together to produce an interactive graphical representation of how a cell divides.

MEDIA RELEASE: May 16, 2017 10:42 PM

Tumour-trained T cells go on patrol

‘Tumour-trained’ immune cells – which have the potential to kill cancer cells – have been seen moving from one tumour to another for the first time. The new findings, which were uncovered by scientists at Sydney’s Garvan...

May 05, 2017 11:00 AM

The path to understanding Parkinson’s disease

Ask any navigator: to get anywhere, it helps to consult a map. And if you don’t have a map, make one.

MEDIA RELEASE: Apr 11, 2017 12:53 PM

Mapping the genome of prostate cancer uncovers a new world o...

Researchers have ‘mapped’ the entire genome of a prostate tumour, revealing previously undetected levels of DNA rearrangements. The findings, from the Garvan Institute of Medical Research, provide an entirely new lens th...

MEDIA RELEASE: Apr 07, 2017 02:00 AM

“The best tool of its kind in the world”: Patient Archive be...

Western Australia’s Undiagnosed Diseases Program (UDP) has acquired Patient Archive clinical phenotyping software from the Garvan Institute of Medical Research.

MEDIA RELEASE: Apr 06, 2017 04:00 AM

A one-two punch for pancreatic cancer: ‘softening’ tumours b...

Australian scientists have uncovered a promising new approach to treating pancreatic cancer, by targeting the tissue around the tumour to make it ‘softer’ and more responsive to chemotherapy. The findings are published t...

MEDIA RELEASE: Dec 16, 2016 09:00 AM

Genomes of healthy older Australians to accelerate medical r...

Information about the genome sequence of 1200 of Australia’s healthy older people has been made available to medical researchers worldwide, with the launch of the Medical Genome Reference Bank today by Garvan and NSW Hea...

Nov 25, 2016 05:14 PM

Paspaley’s Kimberley Bracelet for cancer research

Paspaley recently released the 'Kimberley Bracelet' to support Garvan’s cancer research. 20% of the purchase price is donated to Garvan, with Paspaley customers choosing which area of cancer research to support.

MEDIA RELEASE: Nov 10, 2016 09:00 PM

Die Another Day: how the immune system keeps ‘traitor cells’...

Australian researchers have uncovered how our immune system strikes a balance between attacking invaders and leaving our own tissues alone – and, in the process, have solved a 50-year mystery surrounding the role of an e...

Sep 08, 2016 09:29 AM

‘Forgotten molecule’ takes centre stage in cancer gene silen...

Research from Garvan’s Genomics and Epigenetics Division has shed new light on how genes are silenced in cancer. The findings reveal how DNA becomes chemically decorated (methylated) at key sites across the genome in can...

MEDIA RELEASE: Aug 09, 2016 01:05 AM

Navigating the human genome with Sequins

Australian genomics researchers have announced the development of Sequins – synthetic ‘mirror’ DNA sequences that reflect the human genome. This intuitive new technology, which can be used to better map and analyse compl...